PATENT CLAIM ANALYSIS

Application Number: 15742947
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "415000"]

Abstract:
Indoline and tetrahydroquinoline sulfonyl compounds that can inhibit DapE and/or bacterial metallo-62 -lactamases (“MBLs”), such as NDM-1 are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the compounds disclosed herein.

Claim (Index 38):
The compound of any one of  claims 1  to  37 , wherein R 2  is C 1-6 alkyl, C 2-6 alkenyl, C 1-4 alkylene-OH, C 1-4 alkylene-CN, or C 1-4 alkylene-halo.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15501489', '10851428', '15323081', '10888849', '14146643']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7602862671437924
- 35 USC 102 Novelty (BERT): 0.5071972791400595
- Combined Prediction Score: 0.7349773683434191
- Mean Citation Score: 231.8951
- Max Citation Score: 258.33267
- Similarity Product: 179.80747842507716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test